Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
PET imaging using radiolabeled amino acids in addition to MRI has become a valuable diagnostic tool in the clinical management of patients with brain tumors. This review provides a comprehensive overview of PET studies in glioma patients with a mutation in the isocitrate dehydrogenase gene (IDH). A considerable fraction of these tumors typically show no contrast enhancement on MRI, especially when classified as grade 2 according to the World Health Organization classification of Central Nervous System tumors. Major diagnostic challenges in this situation are differential diagnosis, target definition for diagnostic biopsies, delineation of glioma extent for treatment planning, differentiation of treatment-related changes from tumor progression, and the evaluation of response to alkylating agents. The main focus of this review is the role of amino acid PET in this setting. Furthermore, in light of clinical trials using IDH inhibitors targeting the mutated IDH enzyme for treating patients with IDH-mutant gliomas, we also aim to give an outlook on PET probes specifically targeting the IDH mutation, which appear potentially helpful for response assessment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227162 | PMC |
| http://dx.doi.org/10.1007/s11060-022-04218-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploring seasonal fluctuations in dopamine D2/D3 receptor availability in healthy adults: A [C]PHNO PET study.
J Affect Disord
September 2025
Department of Radiology and Biomedical Imaging, Yale University, New Haven, CT, USA; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA; Department of Neurology, Yale University, New Haven, CT, USA. Electronic address:
Purpose: Dopamine is a neurotransmitter implicated in functions ranging from motor control to cognitive performance. In humans, dopaminergic markers have been associated with seasonal symptomatic fluctuations. Here we investigated potential seasonal variations in dopamine D2/D3 receptor availability in healthy adults using [C]PHNO positron emission tomography (PET) imaging.
View Article and Find Full Text PDFRelevancy Aware Cascaded Generative Adversarial Network for LSO-transmission Image Denoising in CT-less PET.
Biomed Phys Eng Express
September 2025
Siemens Healthineers AG, 810 Innovation Dr, Knoxville, Tennessee, 37932-2562, UNITED STATES.
Achieving high-quality PET imaging while minimizing scan time and patient radiation dose presents significant challenges, particularly in the absence of CT-based attenuation maps. Joint reconstruction algorithms, such as MLAA and MLACF, partially address these challenges but often result in noisy and less reliable images. Denoising these images is critical for enhancing diagnostic accuracy.
View Article and Find Full Text PDFFixed point method for PET reconstruction with learned plug-and-play regularization.
Phys Med Biol
September 2025
BioMaps, Université Paris-Saclay, CNRS, Inserm, SHFJ, CEA, 4 Place du général Leclerc, Orsay, Île-de-France, 91401, FRANCE.
Deep learning has shown great promise for improving medical image reconstruction, including PET. However, concerns remain about the stability and robustness of these methods, especially when trained on limited data. This work aims to explore the use of the Plug-and-Play (PnP) framework in PET reconstruction to address these concerns.
View Article and Find Full Text PDFPerformance evaluation of a multiplexing circuit combined with ASIC readout for cost-effective brain PET imaging.
Phys Med Biol
September 2025
Institute for Instrumentation in Molecular Imaging (i3M), Consejo Superior de Investigaciones Cientificas, Camino de Vera s/n, Valencia, Valencia, 46022, SPAIN.
A key challenge in PET systems is collecting large amount of data with the most accurate information-time, energy, and position-to produce high-resolution images while limiting the number of channels to reduce costs and improve data collection efficiency. The new Ultra-High-performance Brain (UHB) scanner under development aims to tackle this issue, using a semi-monolithic detector that combines pixelated arrays and monolithic designs, along with signal multiplexing techniques. Approach.
View Article and Find Full Text PDFPET radiotracer targeting the complement C3a receptor.
Nucl Med Biol
September 2025
The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, USA. Electronic address:
Background: Positron-emission tomography (PET) imaging of the complement system could advance understanding of the innate immune system in central nervous system (CNS) diseases and development of new drugs. The goal of this study was to develop a PET radiotracer targeting the C3a receptor (C3aR) of the complement system.
Methods: C3aR radiotracer [F]1 was synthesized in one step.